Viewing Study NCT05401357

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2026-06-17 @ 6:08 PM
Study NCT ID: NCT05401357
Status: RECRUITING
Last Update Posted: 2022-08-10
First Post: 2022-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Sponsor: Amneal Pharmaceuticals, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma, Open-Angle View
None Ocular Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bimatoprost ophthalmic solution 0.01% in both eyes View
None Chronic open-angle glaucoma in both eyes View